Irritable Bowel Syndrome

CHICAGO — This weekend, Healio Gastroenterology and Liver Disease will provide live coverage at the 2019 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting.

A non-invasive device that delivers neurostimulation to the external ear reduced pain scores and improved overall well-being in children with irritable bowel syndrome, according to study results.

Healio Gastroenterology and Liver Disease has compiled a list of some of the top stories we reported in September.

The American Gastroenterological Association released new clinical practice guidelines for the evaluation of chronic diarrhea.

News that the FDA approved Ibsrela to treat irritable bowel syndrome with constipation in adults and the American Society for Gastrointestinal Endoscopy’s updates to its guidelines for screening and surveillance of Barrett’s esophagus were among the top stories in gastroenterology last week.

Healio Gastroenterology and Liver Disease has compiled a list of some of the most recent approvals and updates from the FDA.

Among the top stories in gastroenterology last week were a study that found moderate consumption of red wine helped to promote better diversity in the gut microbiome, and phase 1 study results that demonstrated the potential of a novel therapy for gastroesophageal reflux disease.

Recently, a study found that oral antibiotics were associated with a risk for colorectal cancer, and post-marketing data showed that over-the-counter peppermint oil treatment effectively managed symptoms of irritable bowel syndrome without the side effect of heartburn. These were among last week’s top stories.

Although it did not meet stringent recommended endpoints dictated by the FDA and European Medicines Agency, small intestinal-release peppermint oil reduced abdominal pain, discomfort and severity in patients with irritable bowel syndrome, according to study results.

In a post-marketing study, the manufacturer of IBgard showed that over-the-counter peppermint oil treatment effectively managed symptoms of irritable bowel syndrome without the side effect of heartburn.